Established 2013
Correlia Biosystems is creating next generation proteomic technology that integrates complex assays such as ELISA or other immunoassays into rapid, automated and portable platforms for pharma and diagnostic use.
Correlia Biosystems is creating next generation proteomic technology that integrates complex assays such as ELISA or other immunoassays into rapid, automated and portable platforms for pharma and diagnostic use.